Ovarian and Peritoneal Borderline Neoplasms: Histopathology,Diagnostic Pitfalls,and Prognostication

Abstract

Get full access to this article

View all access options for this article.

References

Wingo

P.A.

, Tong

, Bolden

Cancer statistics, 1995. CA Cancer J Clin. 1995; 45: 8–30.

Nicosia

S.V.

, Nicosia

R.F.

Neoplasms of ovarian mesothelium. In: Azar

H.A.

, ed. Pathology of Human Neoplasms. New York, NY: Raven Press; 1988: 435–486.

Cavanagh

, Marsden

D.E.

, Ruffolo

E.H.

Epithelial carcinoma of the ovary. Obstet Gynecol Annu. 1983; 12: 311–364.

Bell

D.A.

Ovarian surface epithelial-stromal tumors. Hum Pathol. 1991; 22: 750–762.

Czernobilsky

Primary epithelial tumors of the ovary In: Blaustein

, ed. Pathology of the Female Genital Tract. 2nd ed. New York, NY: Springer-Verlag; 1982: 511–560.

Russell

The pathological assessment of ovarian neoplasms: II. The proliferating “epithelial” tumours. Pathology. 1979; 11: 251–282.

Harlow

B.L.

, Weiss

N.S.

, Roth

G.J.

Case-control study of borderline ovarian tumors: reproductive history and exposure to exogenous hormones. Cancer Res. 1988; 48: 5849–5852.

Kurman

R.J.

, Trimble

C.L.

The behavior of serous tumors of low malignant potential: are they ever malignant?

Int J Gynecol Pathol. 1993; 12: 120–127.

Mittal

K.R.

, Zeleniuch-Jacquotte

, Cooper

J.L.

Contralateral ovary in unilateral ovarian carcinoma: a search for preneoplastic lesions. Int J Gynecol Pathol. 1993; 12: 59–63.

10.

Fox

Pathology of early malignant change in the ovary. Int J Gynecol Pathol. 1993; 12: 153–155.

11.

McCaughey

W.T.

, Kirk

M.E.

, Lester

Peritoneal epithelial lesions associated with proliferative serous tumors of ovary. Histopathology. 1984; 8: 195–208.

12.

Nicosia

S.V.

, Saunders

B.O.

, Acevedo-Duncan

M.E.

Pathobiology of ovarian mesothelium. In: Familiari

, Makabe

, Motta

P.M.

, eds. Ultrastructure of the Ovary. Boston, Mass: Kluwer Academic Publishers; 1991: 287–310.

13.

Nicosia

S.V.

, Nicosia

R.F.

, Saunders

Control of papillogenesis in normal and neoplastic ovarian mesothelium. Front Endocrinol. 1995; 13: 332–343.

14.

Pierro

, Nicosia

S.V.

, Saunders

Influence of growth factors on proliferation and morphogenesis of ovarian mesothelial cells in vitro. Biol Reprod. 1996; 54: 660–669.

15.

Colgan

T.J.

, Norris

H.J.

Ovarian epithelial tumors of low malignant potential. Int J Gynecol Pathol. 1983; 1: 367–382.

16.

Tavassoli

F.A.

Serous tumors of low malignant potential with early stromal invasion (serous LMP with microinvasion). Mod Pathol. 1988; 1: 407–414.

17.

Hanselaar

A.G.

, Vooijs

G.P.

, Mayall

Epithelial markers to detect occult microinvasion in serous ovarian tumors. Int J Gynecol Pathol. 1993; 12: 20–27.

18.

Aure

J.C.

, Hoeg

, Kolstad

Clinical and histologic studies of ovarian carcinoma: long- term follow-up of 990 cases. Obstet Gynecol. 1971; 37: 1–9.

19.

Baak

J.P.

, Wisse-Brekelmans

E.C.

, Uyterlinde

A.M.

Evaluation of the prognostic value of morphometric features and cellular DNA content in FIGO I ovarian cancer patients. Anal Quant Cytol Histol. 1987; 9: 287–290.

20.

Friedlander

M.L.

, Russell

, Taylor

I.W.

Flow cytometric analysis of cellular DNA content as an adjunct to the diagnosis of ovarian tumours of borderline malignancy. Pathology. 1984; 16: 301–306.

21.

Griffiths

A.P.

, Cross

, Kingston

R.E.

Flow cytometry and AgNORs in benign, borderline, and malignant mucinous and serous tumours of the ovary. Int J Gynecol Pathol. 1993; 12: 307–314.

22.

Kallioniemi

O.P.

, Punnonen

, Mattila

Prognostic significance of DNA Index, multiploidy, and S-phase fraction in ovarian cancer. Cancer. 1988; 61: 334–339.

23.

Kotylo

P.K.

, Michael

, Fineberg

Flow cytometric analysis of DNA content and ras p21 oncoprotein expression in ovarian neoplasms. Int J Gynecol Pathol. 1992; 11: 30–37.

24.

Klemi

P.J.

, Takahashi

, Joensuu

Immunohistochemical detection of p53 protein in borderline and malignant serous ovarian tumors. Int J Gynecol Pathol. 1994; 13: 228–233.

25.

Khattech

, Spatz

, Prade

Nucleolar organizer regions in ovarian tumors: discrimination between carcinoma and borderline tumor. Int J Gynecol Pathol. 1992; 11: 11–14.

26.

Criscuolo

, Martinelli

A.M.

, Migaldi

Prognostic significance of nucleolar organizer regions in ovarian epithelial tumors. Int J Gynecol Pathol. 1993; 12: 259–263.

27.

Mountford

C.E.

, Saunders

J.K.

, May

G.L.

Classification of human tumours by high- resolution magnetic resonance spectroscopy. Lancet. 1986; 1: 651–653.

28.

Hart

W.R.

, Norris

H.J.

Borderline and malignant mucinous tumors of the ovary: histologic criteria and clinical behaviour. Cancer. 1973; 31: 1031–1045.

29.

Chaitin

B.A.

, Gershenson

D.M.

, Evans

H.L.

Mucinous tumors of the ovary: a clinicopathological study of 70 cases. Cancer. 1985; 55: 1958–1962.

30.

Kahn

M.A.

, Demopoulos

R.I.

Mucinous ovarian tumors with pseudomyxoma peritonei: a clinicopathological study. Int J Gynecol Pathol. 1992; 11: 15–23.

31.

Zinsser

K.R.

, Wheeler

J.E.

Endosalpingiosis in the omentum: a study of autopsy and surgical material. Am J Surg Pathol. 1982; 6: 109–117.

32.

Russell

, Bannatyne

M llerianosis and surface proliferative lesions. In: Russell

, Bannatyne

, eds. Surgical Pathology of the Ovaries. Edinburgh, Scotland: Churchill Livingstone; 1989: 157–187.

33.

Froboese

Peritonitis arenosa und epiploitis fibroplastica calcificans (ossificans). Virchows Arch A Pathol Anat Histopathol. 1950; 317: 616–653.

34.

Bell

D.A.

, Weinstock

M.A.

, Scully

R.E.

Peritoneal implants of ovarian serous borderline tumors: histologic features and prognosis. Cancer. 1988; 62: 2212–2222.

35.

Clement

P.B.

, Young

R.H.

Florid mesothelial hyperplasia associated with ovarian tumors: a potential source of error in tumor diagnosis and staging. Int J Gynecol Pathol. 1993; 12: 51–58.

36.

Nicosia

S.V.

, Erkamn-Balis

, LaPolla

An immunocytochemical study of reactive mesothelia, benign glandular inclusions and ovarian carcinomas in “second look” peritoneal washings. Lab Invest. 1988; 58: 67a.

37.

Bell

D.A.

, Scully

R.E.

Serous borderline tumors of the peritoneum. Am J Surg Pathol. 1990; 14: 230–239.

38.

Burmeister

R.E.

, Fechner

R.E.

, Franklin

R.R.

Endosalpingiosis of the peritoneum. Obstet Gynecol. 1969; 34: 310–318.

39.

Pickartz

Differential diagnosis of peritoneal lesions of mullerian type and similar epithelial tumors of the peritoneum. Int J Gynecol Pathol. 1993; 12: 116–119.

40.

Prade

, Spatz

, Bentley

Borderline and malignant serous tumor arising in pelvic lymph nodes: evidence of origin in benign glandular inclusions. Int J Gynecol Pathol. 1995; 14: 87–91.

41.

Dallenbach-Hellweg

Atypical endosalpingiosis: a case report with consideration of the differential diagnosis of glandular subperitoneal inclusions. Pathol Res Pract. 1987; 182: 180–182.

42.

Woodruff

J.D.

The pathogenesis of ovarian neoplasia. Johns Hopkins Med J. 1979; 144: 117–120.

43.

Heinonen

P.K.

, Morsky

, Aine

Hormonal activity of epithelial ovarian tumours in post-menopausal women. Maturitas. 1988; 9: 325–338.

44.

Klemi

P.J.

, Joensuu

, Kiilholma

Clinical significance of abnormal nuclear DNA content in serous ovarian tumours. Cancer. 1988; 62: 2005–2010.

45.

Iversen

O.E.

, Skaarland

Ploidy assessment of benign and malignant ovarian tumours by flow cytometry: a clinicopathologic study. Cancer. 1987; 60: 82–87.

46.

Kuhn

, Kaufmann

, Feichter

G.E.

DNA flow cytometry, clinical and morphological parameters as prognostic factors for advanced malignant and borderline ovarian tumors. Gynecol Oncol. 1989; 33: 360–367.

47.

Watson

J.V.

, Curling

O.M.

, Munn

C.F.

Oncogene expression in ovarian cancer: a pilot study of c-myc oncoprotein in serous papillary ovarian cancer. Gynecol Oncol. 1987; 28: 137–150.

48.

Marcelli

A.R.

, Demopoulos

R.I.

, Goswanni

Comparison of p53 and MIB1 expression in benign and borderline areas of ovarian serous tumors. Int J Gynecol Pathol. 1996; 15: 39–44.

49.

Stromberg

, Johnson

G.R.

, O'Connor

D.M.

Frequent immunohistochemical detection of EGF supergene family members in ovarian carcinogenesis. Int J Gynecol Pathol. 1994; 13: 342–347.

50.

Calugi

, Eleuteri

, Cavallo

Detection of cellular heterogeneity by DNA ploidy, 17 chromosome, and p53 gene in primary carcinoma and metastasis in a case of ovarian cancer. Int J Gynecol Pathol. 1996; 15: 77–81.